Cargando…

Erianin Induces Ferroptosis of Renal Cancer Stem Cells via Promoting ALOX12/P53 mRNA N6-methyladenosine Modification

Renal cell carcinoma (RCC) is the most common type of primary renal parenchymal malignancy in adults, with a high degree of malignancy and poor prognosis. Human renal cancer stem cells (HuRCSCs) are reported to be the main cause of drug resistance, metastasis, recurrence, and poor prognosis. Erianin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Hongliang, Geng, Zixiang, Nie, Xiaoli, Liu, Te
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969579/ https://www.ncbi.nlm.nih.gov/pubmed/36860916 http://dx.doi.org/10.7150/jca.81027

Ejemplares similares

ALOX12 is required for p53-mediated tumor suppression through a distinct ferroptosis pathway
por: Chu, Bo, et al.
Publicado: (2019)

Atranorin driven by nano materials SPION lead to ferroptosis of gastric cancer stem cells by weakening the mRNA 5-hydroxymethylcytidine modification of the Xc-/GPX4 axis and its expression
por: Ni, Zhentian, et al.
Publicado: (2022)

Hydroperoxidation of Docosahexaenoic Acid by Human ALOX12 and pigALOX15-mini-LOX
por: Canyelles-Niño, Miquel, et al.
Publicado: (2023)

Connecting N6‐methyladenosine modification to ferroptosis resistance in hepatoblastoma
por: Peng, Wan‐Xin, et al.
Publicado: (2022)

Erianin: A phytoestrogen with therapeutic potential
por: Li, Gangmin, et al.
Publicado: (2023)

Activation of ALOX12 by a multi-organelle-orienting photosensitizer drives ACSL4-independent cell ferroptosis
por: Wang, Xiuxia, et al.
Publicado: (2022)

The N6‐methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma
por: Liu, Li, et al.
Publicado: (2022)

Dihydroorotate dehydrogenase regulates ferroptosis in neurons after spinal cord injury via the P53‐ALOX15 signaling pathway
por: Li, Dachuan, et al.
Publicado: (2023)

Natural Product Erianin Inhibits Bladder Cancer Cell Growth by Inducing Ferroptosis via NRF2 Inactivation
por: Xiang, Yu, et al.
Publicado: (2021)

Progressive study of effects of erianin on anticancer activity
por: Zhang, Yuying, et al.
Publicado: (2019)

Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients
por: Hotz, Alrun, et al.
Publicado: (2021)

N(6)-Methyladenosine mRNA Modification: From Modification Site Selectivity to Neurological Functions
por: Zhang, Zeyu, et al.
Publicado: (2023)

The roles of ERIANIN in tumor and innate immunity and its’ perspectives in immunotherapy
por: Yang, Zhen, et al.
Publicado: (2023)

ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage
por: Ma, Xiao-Hui, et al.
Publicado: (2022)

The suppression of cervical cancer ferroptosis by macrophages: The attenuation of ALOX15 in cancer cells by macrophages-derived exosomes
por: Luo, Yanlin, et al.
Publicado: (2023)

Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis
por: Chen, Peng, et al.
Publicado: (2020)

The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease
por: Cai, Teng, et al.
Publicado: (2022)

Reversible RNA Modification N(1)-methyladenosine (m(1)A) in mRNA and tRNA
por: Zhang, Chi, et al.
Publicado: (2018)

N(6)-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells
por: Shen, Min, et al.
Publicado: (2021)

Erianin against Staphylococcus aureus Infection via Inhibiting Sortase A
por: Ouyang, Ping, et al.
Publicado: (2018)

Dual Targeting of Cell Growth and Phagocytosis by Erianin for Human Colorectal Cancer
por: Sun, Yihan, et al.
Publicado: (2020)

Ferroptosis-Related APOE, BCL3 and ALOX5AP Gene Polymorphisms are Associated with the Risk of Thyroid Cancer
por: Xiao, Zhifu, et al.
Publicado: (2022)

Association between polymorphisms of arachidonate 12-lipoxygenase (ALOX12) and schizophrenia in a Korean population
por: Kim, Tae, et al.
Publicado: (2010)

N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
por: Jin, Huan, et al.
Publicado: (2019)

N6-methyladenosine modification governs liver glycogenesis by stabilizing the glycogen synthase 2 mRNA
por: Zhang, Xiang, et al.
Publicado: (2022)

Hypermethylation of the ALOX12 and CBS promoters in osteoporosis: Potential biomarkers for early diagnosis
por: Guo, Shang, et al.
Publicado: (2023)

METTL14-mediated N(6)-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma
por: Liu, Zhuonan, et al.
Publicado: (2022)

Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration
por: Shu, Liqi, et al.
Publicado: (2021)

Dysregulation and implications of N6-methyladenosine modification in renal cell carcinoma
por: Wu, Yaohai, et al.
Publicado: (2023)

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2
por: Wang, Penglei, et al.
Publicado: (2023)

Erianin: A Direct NLRP3 Inhibitor With Remarkable Anti-Inflammatory Activity
por: Zhang, Xinyong, et al.
Publicado: (2021)

Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology
por: Yan, Lili, et al.
Publicado: (2022)

Oncogenic Activation of YAP Signaling Sensitizes Ferroptosis of Hepatocellular Carcinoma via ALOXE3-Mediated Lipid Peroxidation Accumulation
por: Qin, Yifei, et al.
Publicado: (2021)

ALOX5-mediated ferroptosis acts as a distinct cell death pathway upon oxidative stress in Huntington's disease
por: Song, Shujuan, et al.
Publicado: (2023)

METTL3-mediated N(6)-methyladenosine mRNA modification enhances long-term memory consolidation
por: Zhang, Zeyu, et al.
Publicado: (2018)

WTAP-mediated N(6)-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy
por: Lan, Jianzi, et al.
Publicado: (2022)

N(6)-methyladenosine-modified lncRNA and mRNA modification profiles in cerebral ischemia-reperfusion injury
por: Shao, Le, et al.
Publicado: (2022)

Promoter methylation changes in ALOX12 and AIRE1: novel epigenetic markers for atherosclerosis
por: Kim, Jee Yeon, et al.
Publicado: (2020)

Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
por: Tsai, Sen-Wei, et al.
Publicado: (2023)

Genetic Analyses Support the Contribution of mRNA N(6)-methyladenosine (m(6)A) Modification to Human Disease Heritability
por: Zhang, Zijie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fq05k76ja9m1m3amqjop34jlaq